NO963848L - Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon - Google Patents

Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon

Info

Publication number
NO963848L
NO963848L NO963848A NO963848A NO963848L NO 963848 L NO963848 L NO 963848L NO 963848 A NO963848 A NO 963848A NO 963848 A NO963848 A NO 963848A NO 963848 L NO963848 L NO 963848L
Authority
NO
Norway
Prior art keywords
diagnosing
infection
treating hiv
hiv
treating
Prior art date
Application number
NO963848A
Other languages
English (en)
Norwegian (no)
Other versions
NO963848D0 (no
Inventor
Angeline Douvas
Glenn Ehresmann
Yoshi Takehana
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of NO963848D0 publication Critical patent/NO963848D0/no
Publication of NO963848L publication Critical patent/NO963848L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO963848A 1994-03-14 1996-09-13 Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon NO963848L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21374394A 1994-03-14 1994-03-14
PCT/US1995/003236 WO1995025124A1 (en) 1994-03-14 1995-03-13 Methods to diagnose and treat hiv-1 infection

Publications (2)

Publication Number Publication Date
NO963848D0 NO963848D0 (no) 1996-09-13
NO963848L true NO963848L (no) 1996-11-14

Family

ID=22796323

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963848A NO963848L (no) 1994-03-14 1996-09-13 Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon

Country Status (6)

Country Link
EP (1) EP0750636A1 (ja)
JP (1) JPH10504798A (ja)
CA (1) CA2185129A1 (ja)
FI (1) FI963638A (ja)
NO (1) NO963848L (ja)
WO (1) WO1995025124A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
DE60234843D1 (de) * 2001-09-06 2010-02-04 Centre Nat Rech Scient Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
CN101588813A (zh) * 2005-04-12 2009-11-25 杜克大学 诱导人类免疫缺陷病毒的中和抗体的方法
TW200726479A (en) 2005-04-12 2007-07-16 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
EP2139516A4 (en) 2007-04-13 2011-06-29 Univ Duke METHOD FOR INDUCING NEUTRALIZING ANTIBODIES AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS
AU2010232915A1 (en) 2009-04-03 2011-10-20 Duke University Formulation for inducing broadly reactive neutralizing anti-HIV antibodies
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
FI963638A0 (fi) 1996-09-13
WO1995025124A1 (en) 1995-09-21
FI963638A (fi) 1996-11-13
CA2185129A1 (en) 1995-09-21
AU2120595A (en) 1995-10-03
EP0750636A1 (en) 1997-01-02
JPH10504798A (ja) 1998-05-12
NO963848D0 (no) 1996-09-13
AU694204B2 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
KR960008976A (ko) 처리장치 및 처리방법
NO970532D0 (no) System og metode for blodbehandling
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
NO973836D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
FI973378A0 (fi) Laite ja menetelmä
NO933743L (no) Fremgangsmåte og system for gjennomföring av endoskop-kirurgi
KR970700962A (ko) 멀티유저-간섭 감소 장치 및 방법과 코드분할 다중 액세스 통신 시스템(method and apparatus for multiuser-interference reduction)
DE69612411D1 (de) Unterwasserbehandlungsverfahren und -system
DE59807358D1 (de) Prozessdiagnosesystem und -Verfahren
BR9510353A (pt) Estação e método de tratamento de água servida
NO970543D0 (no) Fremgangsmåte og system for forutsigelse av blodbehandlingsparametere
NO963416L (no) Fremgangsmåte og anordning for gassbehandling
DE69609959D1 (de) Abgasbehandlung
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
ID17194A (id) Metode pengobatan inflamasi
DE69515626D1 (de) Plasmabehandlungsverfahren und -vorrichtung
KR960016661A (ko) 피이크형 유전성 댐(Peak-shaped Dam)을 갖는 장치 및 그 제조 방법
DE69631282D1 (de) Blutverarbeitungssystem und verfahren
EE9600094A (et) Heitvee puhastusmeetod ja -seade
DE69514960T2 (de) Schlackbehandlungssystem und -methode
DE69536034D1 (de) Belichtungsapparat und Belichtungsverfahren
NO963848D0 (no) Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon
NO963366D0 (no) Peptider og fremgangsmåte for behandling av diabetes
NO963978D0 (no) Anordning og fremgangsmåte til behandling av crustaceaner
DE59508386D1 (de) Verarbeitungssystem und Verarbeitungsverfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application